Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients

Abstract Risk factors associated with severity and mortality attributable to COVID-19 have been reported in different cohorts, highlighting the occurrence of acute kidney injury (AKI) in 25% of them. Among other, SARS-CoV-2 targets renal tubular cells and can cause acute renal damage. The aim of the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Morell-Garcia, David Ramos-Chavarino, Josep M. Bauça, Paula Argente del Castillo, Maria Antonieta Ballesteros-Vizoso, Luis García de Guadiana-Romualdo, Cristina Gómez-Cobo, J. Albert Pou, Rocío Amezaga-Menéndez, Alberto Alonso-Fernández, Isabel Llompart, Ana García-Raja
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/855c9467842e421fac6a10f78da39965
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:855c9467842e421fac6a10f78da39965
record_format dspace
spelling oai:doaj.org-article:855c9467842e421fac6a10f78da399652021-12-02T15:49:31ZUrine biomarkers for the prediction of mortality in COVID-19 hospitalized patients10.1038/s41598-021-90610-y2045-2322https://doaj.org/article/855c9467842e421fac6a10f78da399652021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90610-yhttps://doaj.org/toc/2045-2322Abstract Risk factors associated with severity and mortality attributable to COVID-19 have been reported in different cohorts, highlighting the occurrence of acute kidney injury (AKI) in 25% of them. Among other, SARS-CoV-2 targets renal tubular cells and can cause acute renal damage. The aim of the present study was to evaluate the usefulness of urinary parameters in predicting intensive care unit (ICU) admission, mortality and development of AKI in hospitalized patients with COVID-19. Retrospective observational study, in a tertiary care hospital, between March 1st and April 19th, 2020. We recruited adult patients admitted consecutively and positive for SARS-CoV-2. Urinary and serum biomarkers were correlated with clinical outcomes (AKI, ICU admission, hospital discharge and in-hospital mortality) and evaluated using a logistic regression model and ROC curves. A total of 199 COVID-19 hospitalized patients were included. In AKI, the logistic regression model with a highest area under the curve (AUC) was reached by the combination of urine blood and previous chronic kidney disease, with an AUC of 0.676 (95%CI 0.512–0.840; p = 0.023); urine specific weight, sodium and albumin in serum, with an AUC of 0.837 (95% CI 0.766–0.909; p < 0.001) for ICU admission; and age, urine blood and lactate dehydrogenase levels in serum, with an AUC of 0.923 (95%CI 0.866–0.979; p < 0.001) for mortality prediction. For hospitalized patients with COVID-19, renal involvement and early alterations of urinary and serum parameters are useful as prognostic factors of AKI, the need for ICU admission and death.Daniel Morell-GarciaDavid Ramos-ChavarinoJosep M. BauçaPaula Argente del CastilloMaria Antonieta Ballesteros-VizosoLuis García de Guadiana-RomualdoCristina Gómez-CoboJ. Albert PouRocío Amezaga-MenéndezAlberto Alonso-FernándezIsabel LlompartAna García-RajaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Daniel Morell-Garcia
David Ramos-Chavarino
Josep M. Bauça
Paula Argente del Castillo
Maria Antonieta Ballesteros-Vizoso
Luis García de Guadiana-Romualdo
Cristina Gómez-Cobo
J. Albert Pou
Rocío Amezaga-Menéndez
Alberto Alonso-Fernández
Isabel Llompart
Ana García-Raja
Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
description Abstract Risk factors associated with severity and mortality attributable to COVID-19 have been reported in different cohorts, highlighting the occurrence of acute kidney injury (AKI) in 25% of them. Among other, SARS-CoV-2 targets renal tubular cells and can cause acute renal damage. The aim of the present study was to evaluate the usefulness of urinary parameters in predicting intensive care unit (ICU) admission, mortality and development of AKI in hospitalized patients with COVID-19. Retrospective observational study, in a tertiary care hospital, between March 1st and April 19th, 2020. We recruited adult patients admitted consecutively and positive for SARS-CoV-2. Urinary and serum biomarkers were correlated with clinical outcomes (AKI, ICU admission, hospital discharge and in-hospital mortality) and evaluated using a logistic regression model and ROC curves. A total of 199 COVID-19 hospitalized patients were included. In AKI, the logistic regression model with a highest area under the curve (AUC) was reached by the combination of urine blood and previous chronic kidney disease, with an AUC of 0.676 (95%CI 0.512–0.840; p = 0.023); urine specific weight, sodium and albumin in serum, with an AUC of 0.837 (95% CI 0.766–0.909; p < 0.001) for ICU admission; and age, urine blood and lactate dehydrogenase levels in serum, with an AUC of 0.923 (95%CI 0.866–0.979; p < 0.001) for mortality prediction. For hospitalized patients with COVID-19, renal involvement and early alterations of urinary and serum parameters are useful as prognostic factors of AKI, the need for ICU admission and death.
format article
author Daniel Morell-Garcia
David Ramos-Chavarino
Josep M. Bauça
Paula Argente del Castillo
Maria Antonieta Ballesteros-Vizoso
Luis García de Guadiana-Romualdo
Cristina Gómez-Cobo
J. Albert Pou
Rocío Amezaga-Menéndez
Alberto Alonso-Fernández
Isabel Llompart
Ana García-Raja
author_facet Daniel Morell-Garcia
David Ramos-Chavarino
Josep M. Bauça
Paula Argente del Castillo
Maria Antonieta Ballesteros-Vizoso
Luis García de Guadiana-Romualdo
Cristina Gómez-Cobo
J. Albert Pou
Rocío Amezaga-Menéndez
Alberto Alonso-Fernández
Isabel Llompart
Ana García-Raja
author_sort Daniel Morell-Garcia
title Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
title_short Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
title_full Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
title_fullStr Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
title_full_unstemmed Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
title_sort urine biomarkers for the prediction of mortality in covid-19 hospitalized patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/855c9467842e421fac6a10f78da39965
work_keys_str_mv AT danielmorellgarcia urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT davidramoschavarino urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT josepmbauca urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT paulaargentedelcastillo urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT mariaantonietaballesterosvizoso urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT luisgarciadeguadianaromualdo urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT cristinagomezcobo urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT jalbertpou urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT rocioamezagamenendez urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT albertoalonsofernandez urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT isabelllompart urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
AT anagarciaraja urinebiomarkersforthepredictionofmortalityincovid19hospitalizedpatients
_version_ 1718385702164496384